These findings suggest that lncRNA-UCA1 overexpression is orchestrated by the transcription factor HIF-1α in hypoxic breast cancer and that targeting this pathway could be a promising strategy for cancer therapy. This evidence concerns the gene HIF1A and breast carcinoma.